These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 20101529)

  • 1. Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?
    Su B; Wang X; Bonda D; Perry G; Smith M; Zhu X
    Mol Neurobiol; 2010 Jun; 41(2-3):87-96. PubMed ID: 20101529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
    Wang X; Su B; Zheng L; Perry G; Smith MA; Zhu X
    J Neurochem; 2009 May; 109 Suppl 1(Suppl 1):153-9. PubMed ID: 19393022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
    Zhu X; Perry G; Smith MA; Wang X
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S253-62. PubMed ID: 22531428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.
    Pérez MJ; Vergara-Pulgar K; Jara C; Cabezas-Opazo F; Quintanilla RA
    Mol Neurobiol; 2018 Feb; 55(2):1004-1018. PubMed ID: 28084594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.
    Stefanova NA; Muraleva NA; Maksimova KY; Rudnitskaya EA; Kiseleva E; Telegina DV; Kolosova NG
    Aging (Albany NY); 2016 Oct; 8(11):2713-2733. PubMed ID: 27750209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
    Kim DK; Mook-Jung I
    BMB Rep; 2019 Dec; 52(12):679-688. PubMed ID: 31722781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.
    Bonda DJ; Wang X; Perry G; Smith MA; Zhu X
    Drugs Aging; 2010 Mar; 27(3):181-92. PubMed ID: 20210366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium.
    Singulani MP; De Paula VJR; Forlenza OV
    Neurosci Lett; 2021 Aug; 760():136078. PubMed ID: 34161823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.
    Quntanilla RA; Tapia-Monsalves C
    Curr Neuropharmacol; 2020; 18(11):1076-1091. PubMed ID: 32448104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
    Eckert A; Schulz KL; Rhein V; Götz J
    Mol Neurobiol; 2010 Jun; 41(2-3):107-14. PubMed ID: 20217279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
    Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
    Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model.
    Feng T; Yamashita T; Zhai Y; Shang J; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2018 Oct; 1696():63-70. PubMed ID: 29879414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.
    Selfridge JE; E L; Lu J; Swerdlow RH
    Neurobiol Dis; 2013 Mar; 51():3-12. PubMed ID: 22266017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations.
    Mani S; Swargiary G; Singh M; Agarwal S; Dey A; Ojha S; Jha NK
    Life Sci; 2021 Nov; 285():119985. PubMed ID: 34592237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
    Wang X; Su B; Lee HG; Li X; Perry G; Smith MA; Zhu X
    J Neurosci; 2009 Jul; 29(28):9090-103. PubMed ID: 19605646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice.
    Chen Y; Han S; Huang X; Ni J; He X
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26828481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.